NCT05839431

Brief Summary

The purpose of this study is to examine the effectiveness of virtual reality (VR) delivered exposure therapy for youth with phobias or social anxiety, with and without autism spectrum disorder. The study team is also interested in collecting information to better understand phobias and social anxiety.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

July 14, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

July 19, 2024

Status Verified

July 1, 2024

Enrollment Period

9 months

First QC Date

April 20, 2023

Last Update Submit

July 18, 2024

Conditions

Keywords

Virtual Reality

Outcome Measures

Primary Outcomes (1)

  • Client Satisfaction Questionnaire

    The Client Satisfaction Questionnaire is an 8-item measure of client satisfaction with services with both a parent and child version. The total scores range from 8 to 32, with higher scores indicating higher satisfaction.

    Up to 10 weeks

Secondary Outcomes (4)

  • Change in social anxiety as measured by the Severity Measure for Social Anxiety Disorder (Social Phobia)

    Baseline, 10 weeks

  • Change in social anxiety as measured by the Severity Measure for Specific Phobia

    Baseline, 10 weeks

  • Change in intolerance of uncertainty as measured by the Intolerance of Uncertainty Scale for Children

    Baseline, 10 weeks

  • Change in family accommodation as measured by the Family Accommodation Scale-Anxiety

    Baseline, 10 weeks

Study Arms (1)

Virtual Reality Therapy for Youth Phobias

EXPERIMENTAL

Participants will undergo up to 10 weeks of virtual reality-assisted exposure therapy.

Behavioral: Virtual Reality for Youth Phobias

Interventions

The intervention will consist of up to 10, 50-minute-long weekly in-person individual sessions of virtual reality-assisted exposure therapy. This intervention also includes psychoeducation about anxiety/phobias and their maintenance, youth strategies for tolerating distress, and parent strategies for reducing accommodation of anxiety.

Virtual Reality Therapy for Youth Phobias

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The target population for this project are 48 youth (ages of 8-16) that meet criteria for a specific phobia or social anxiety disorder within Miami-Dade County.
  • Youth will be eligible if they or their parent report clinically significant symptoms of social anxiety disorder or a specific phobia targeted with the VR program, based on self- or parent-report scores on online screening measures (\>1 average total scores on Severity Measure for Specific Phobia-Child or Social Anxiety Disorder-Child) or clinician-report diagnosis (i.e., diagnosed with Social Anxiety Disorder or Specific Phobia during clinical interview).
  • Youth are able to complete study procedures, speak/read English or Spanish sufficiently.
  • Youth have at least one caregiver who can complete all study measures in English or Spanish.
  • Youth have a caregiver who is available to sign study consent forms, remain present during assessments, and fill out study questionnaires.

You may not qualify if:

  • Youth who would be inappropriate for a brief VR-exposure therapy protocol will be referred to local resources for additional support or provided with alternate cognitive behavioral therapy services through the clinical center in which this program takes place.
  • Research staff will review all measures and the youth's psychological history and consult with the PI to ensure that the participant does not have a current diagnosis of psychosis, bipolar disorder, acute suicidality, alcohol/substance dependence, or eating disorder.
  • Youth will also be excluded if they are currently receiving psychotherapy elsewhere.
  • Youth with co-occurring intellectual disability may be eligible, but youth who are non-verbal will not be eligible, as some verbal abilities are necessary in order to communicate with the clinician during the intervention.
  • Youth who are currently suicidal or who have engaged in suicidal behaviors within the past 6 months will be excluded (or discussed on a case-by-case basis).
  • Youth who engage in self-harm behaviors (e.g., cutting) and who do not present with suicidal intent will be allowed to participate.
  • If youth develop psychiatric problems (e.g., severe depression, acute suicidal ideation/intent, severe conduct problems) that require a higher level of care, youth will be withdrawn from the study and referred for appropriate treatment.
  • Youth currently taking psychotropic medication for a co-morbid psychiatric illness will be included without a wash-out period (to not delay intervention).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Coral Gables, Florida, 33146, United States

Location

MeSH Terms

Conditions

Phobia, SpecificPhobia, SocialAutism Spectrum Disorder

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental DisordersChild Development Disorders, PervasiveNeurodevelopmental Disorders

Study Officials

  • Jill Ehrenreich-May, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 20, 2023

First Posted

May 3, 2023

Study Start

July 14, 2023

Primary Completion

March 31, 2024

Study Completion

March 31, 2024

Last Updated

July 19, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations